Cullen Frost Bankers Inc. reduced its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 46.2% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 140,345 shares of the pharmacy operator’s stock after selling 120,689 shares during the quarter. Cullen Frost Bankers Inc.’s holdings in Walgreens Boots Alliance were worth $10,837,000 at the end of the most recent reporting period.
Other hedge funds have also recently bought and sold shares of the company. Pathstone Family Office LLC grew its holdings in Walgreens Boots Alliance by 226.6% in the second quarter. Pathstone Family Office LLC now owns 1,179 shares of the pharmacy operator’s stock valued at $1,969,000 after purchasing an additional 818 shares during the last quarter. Hudock Capital Group LLC grew its holdings in Walgreens Boots Alliance by 0.5% in the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after purchasing an additional 6 shares during the last quarter. Westside Investment Management Inc. grew its holdings in Walgreens Boots Alliance by 10.4% in the second quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock valued at $102,000 after purchasing an additional 125 shares during the last quarter. Bristlecone Advisors LLC acquired a new stake in Walgreens Boots Alliance in the third quarter valued at $135,000. Finally, Hanson McClain Inc. grew its holdings in Walgreens Boots Alliance by 4.6% in the second quarter. Hanson McClain Inc. now owns 1,987 shares of the pharmacy operator’s stock valued at $156,000 after purchasing an additional 87 shares during the last quarter. 61.18% of the stock is owned by institutional investors and hedge funds.
Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) traded up $1.30 during trading hours on Thursday, hitting $75.38. The company had a trading volume of 6,281,300 shares, compared to its average volume of 6,500,000. The stock has a market cap of $74,600.00, a P/E ratio of 20.82, a P/E/G ratio of 1.29 and a beta of 1.22. The company has a current ratio of 0.96, a quick ratio of 0.47 and a debt-to-equity ratio of 0.48. Walgreens Boots Alliance Inc has a 1-year low of $63.82 and a 1-year high of $88.00.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.27 by $0.01. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The company had revenue of $30.74 billion for the quarter, compared to the consensus estimate of $30.39 billion. During the same period in the previous year, the business earned $1.10 EPS. Walgreens Boots Alliance’s revenue for the quarter was up 7.9% compared to the same quarter last year. equities research analysts expect that Walgreens Boots Alliance Inc will post 5.59 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Monday, November 13th were issued a dividend of $0.40 per share. The ex-dividend date of this dividend was Friday, November 10th. This represents a $1.60 annualized dividend and a yield of 2.12%. Walgreens Boots Alliance’s dividend payout ratio is presently 44.20%.
Walgreens Boots Alliance declared that its board has initiated a share buyback plan on Wednesday, October 25th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the pharmacy operator to reacquire shares of its stock through open market purchases. Stock buyback plans are often a sign that the company’s board of directors believes its stock is undervalued.
A number of analysts recently commented on WBA shares. Deutsche Bank started coverage on Walgreens Boots Alliance in a research note on Monday, December 4th. They set a “hold” rating and a $78.00 price objective on the stock. Raymond James Financial reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Wednesday, September 27th. Leerink Swann lowered Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating in a research note on Wednesday, November 1st. Loop Capital set a $90.00 price target on Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Thursday, October 26th. Finally, SunTrust Banks set a $72.00 price target on Walgreens Boots Alliance and gave the stock a “hold” rating in a research note on Sunday, October 15th. Nine equities research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the company. Walgreens Boots Alliance currently has an average rating of “Buy” and a consensus price target of $86.15.
In related news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the completion of the transaction, the director now owns 16,415 shares in the company, valued at approximately $1,105,878.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director John Anthony Lederer acquired 20,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, October 26th. The shares were bought at an average price of $67.00 per share, with a total value of $1,340,000.00. Following the transaction, the director now directly owns 50,000 shares in the company, valued at $3,350,000. The disclosure for this purchase can be found here. 14.80% of the stock is owned by insiders.
COPYRIGHT VIOLATION NOTICE: “Cullen Frost Bankers Inc. Reduces Stake in Walgreens Boots Alliance Inc (WBA)” was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this story on another site, it was illegally copied and reposted in violation of US and international copyright & trademark laws. The correct version of this story can be accessed at https://www.dispatchtribunal.com/2018/01/11/cullen-frost-bankers-inc-has-10-84-million-position-in-walgreens-boots-alliance-inc-wba.html.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.